Related Experiment Videos
Neuroleptic-free intervals in the treatment of schizophrenia
The American Journal of Psychiatry
|December 1, 1981
Abstract:
During a period of 1-2 1/2 years the neuroleptic regimen of 14 schizophrenic outpatients was interrupted every 6 months by drug holidays of 6 weeks' duration. As a result, 10 patients achieved a substantially reduced maintenance dose. The authors were unable to predict for whom the drug holidays would be safe.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Program-specific transplant rate ratios: Association with allocation priority at listing and posttransplant outcomes.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2018
Risk factors and peripheral biomarkers for schizophrenia spectrum disorders: an umbrella review of meta-analyses.
Acta psychiatrica Scandinavica·2017
Factors associated with postpartum psychiatric admission in a population-based cohort of women with schizophrenia.
Acta psychiatrica Scandinavica·2016
The Impact of Redistricting Proposals on Health Care Expenditures for Liver Transplant Candidates and Recipients.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2016
Broader Geographic Sharing of Pediatric Donor Lungs Improves Pediatric Access to Transplant.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2015
Schizophrenia and the influence of male gender.
Clinical pharmacology and therapeutics·2015
Age-Associated Cognitive Deviations in Early-Onset Psychosis Patients and Their Siblings.
The American journal of psychiatry·2026
The Longevity of Mental Health Apps: A Survival Analysis of the Largest Mental Health App Database.
The American journal of psychiatry·2026
Comparison of Long-Acting Injectable and Oral Antipsychotics in Bipolar Disorder.
The American journal of psychiatry·2026
New Horizons in the Development of Treatments for Substance Use Disorders.
The American journal of psychiatry·2026
The RECOVER Trial of Vagus Nerve Stimulation in Markedly Treatment-Resistant Depression: Critical Findings, Lessons Learned, and Future Directions.
The American journal of psychiatry·2026
Meta-Analysis: The Placebo Response in Modern Treatments for Cholestatic Pruritus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Alimentary pharmacology & therapeutics·2026
Blood-based biomarkers in Alzheimer's and Parkinson's disease: From molecular pathology to therapeutic potential.
International review of neurobiology·2026
Morphine for End-of-Life Dyspnea: Underuse in the Emergency Department Versus Inpatient Care.
Journal of pain and symptom management·2026
Adverse events during the diagnostic work-up for primary aldosteronism.
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·2026